Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $55

Benzinga Newsdesk www.benzinga.com Positive 65.3%

Neg 0% Neu 0% Pos 65.3%

Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $50 to $55.